The Vaccine Impact Modelling Consortium was launched in late 2016 for a five-year period in response to an identified need by Gavi and the Bill & Melinda Gates Foundation to estimate global vaccine impact more consistently and reliably. The funders use the results to track progress, to project the likely future impact of vaccines in the current portfolio as well as to forecast the impact of potential future investments.

The Consortium coordinates the ongoing work of modelling groups from a range of research institutions and is led by a secretariat based at Imperial College London. We are looking for modelling groups interested in joining the Consortium and able to meet the output requirements as stipulated by the secretariat and the funders. The current portfolio of diseases includes: hepatitis B, Hib (Haemophilus influenzae type b), human papilloma virus (HPV), Japanese encephalitis, measles, meningitis A, pneumococcus, rubella, rotavirus, and yellow fever. We are now looking to expand this scope to include typhoid and cholera.

Through this Request for Proposals (RfP), we are looking to recruit models for typhoid and cholera. At a maximum, the Consortium can fund two modelling groups per disease area.

Timeline:

Closing date: 20 April 2020
Review outcomes: June 2020
Duration: July 2020 - March 2022 (or April 2021 - March 2022)

Funds available: up to USD $65,000 per year

For more information about how to apply, please visit https://www.vaccineimpact.org/2020-02-10-request-for-proposals/